JCO Oncology Practice

JCO Oncology Practice is a monthly journal published since 2005, known until 2019 as the Journal of Oncology Practice, with a 2025 Journal Impact Factor of 5.5.《JCO 肿瘤学实践》（JCO Oncology Practice）为月刊，2005 年创办，2019 年前名为（Journal of Oncology Practice），2025 年影响因子为 5.5。

Scope

• The journal covers the mechanics of oncology care rather than laboratory cancer biology.本刊讨论肿瘤照护的运作机制，而非实验室层面的肿瘤生物学。
• Care delivery, quality improvement and patient safety in oncology practice are core subjects.肿瘤实践中的照护交付、质量改进与患者安全是核心主题。
• Practice management, staffing and the operation of oncology clinics are treated at length.实践管理、人员配置与肿瘤门诊的运营受到重点讨论。
• Health policy, reimbursement and access to cancer care are published.卫生政策、报销与肿瘤照护的可及性均予发表。
• Value in cancer care and equity in the delivery of treatment are prominent themes.肿瘤照护中的价值以及治疗交付中的公平，是其中的突出主题。
• Patient education, shared decision making and survivorship care are within scope.患者教育、共同决策与长期生存者的随访照护均在其范围之内。
• Interprofessional practice and the role of the wider cancer care team are represented.跨专业实践以及更广泛肿瘤照护团队的角色均有收录。

History

• The journal was launched in May 2005 as the Journal of Oncology Practice, with Douglas Blayney of Stanford University as its first editor-in-chief.本刊于 2005 年 5 月以（Journal of Oncology Practice）之名创办，首任主编为斯坦福大学的 Douglas Blayney。
• It is published by the American Society of Clinical Oncology as part of the JCO family of journals.本刊由美国临床肿瘤学会出版，属（JCO）期刊家族。
• Linda D. Bosserman led the journal from 2019, expanding its attention to equity and value in cancer care.Linda D. Bosserman 自 2019 年起主持本刊，把关注面扩展到肿瘤照护中的公平与价值。
• The title was renamed JCO Oncology Practice in 2019, reflecting its place in the JCO series.2019 年本刊更名为（JCO Oncology Practice），以体现其在（JCO）系列中的位置。
• Jeffrey Peppercorn of Massachusetts General Hospital is the current editor-in-chief.（Massachusetts General Hospital）的 Jeffrey Peppercorn 为现任主编。
• Its impact factor stood at 3.487 in 2022, 4.6 in 2024 and 5.5 in 2025, and the journal marked its twentieth anniversary in 2025.其影响因子在 2022 年为 3.487，2024 年为 4.6，2025 年为 5.5，本刊于 2025 年迎来创刊二十周年。

Editors

• Jeffrey Peppercorn of Massachusetts General Hospital leads the journal as editor-in-chief.（Massachusetts General Hospital）的 Jeffrey Peppercorn 担任主编。
• The journal is published by the American Society of Clinical Oncology, with production handled by Lippincott Williams and Wilkins.本刊由美国临床肿瘤学会出版，制作发行由（Lippincott Williams and Wilkins）承担。
• The editorial board spans medical oncology, nursing, pharmacy and health services research.编委会覆盖内科肿瘤学、护理、药学与卫生服务研究。
• Manuscripts are peer reviewed, and the journal publishes original research, reviews, editorials and special series.稿件经同行评审，本刊发表原创研究、综述、社论与特别系列。
• The journal operates a hybrid model, so authors may publish open access on payment of a charge.本刊采用混合模式，作者可付费选择开放获取发表。
• Special series have addressed disparities in cancer care and the delivery of value-based oncology.其特别系列曾讨论肿瘤照护中的差异以及基于价值的肿瘤服务交付。